Disc Medicine, Inc.
IRON
$59.14
-$0.85-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.75M | 17.36M | 15.09M | 12.18M | 9.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.12M | 67.70M | 61.41M | 39.95M | 34.55M |
| Operating Income | -66.12M | -67.70M | -61.41M | -39.95M | -34.55M |
| Income Before Tax | -60.44M | -62.22M | -55.20M | -33.97M | -29.28M |
| Income Tax Expenses | 88.00K | 102.00K | 52.00K | 119.00K | 176.00K |
| Earnings from Continuing Operations | -60.53M | -62.32M | -55.25M | -34.09M | -29.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.53M | -62.32M | -55.25M | -34.09M | -29.46M |
| EBIT | -66.12M | -67.70M | -61.41M | -39.95M | -34.55M |
| EBITDA | -66.03M | -67.61M | -61.33M | -39.93M | -34.54M |
| EPS Basic | -1.61 | -1.77 | -1.58 | -1.02 | -0.98 |
| Normalized Basic EPS | -0.99 | -1.11 | -0.98 | -0.64 | -0.61 |
| EPS Diluted | -1.61 | -1.77 | -1.58 | -1.02 | -0.98 |
| Normalized Diluted EPS | -0.99 | -1.11 | -0.98 | -0.64 | -0.61 |
| Average Basic Shares Outstanding | 37.63M | 35.18M | 35.02M | 33.32M | 30.00M |
| Average Diluted Shares Outstanding | 37.63M | 35.18M | 35.02M | 33.32M | 30.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |